Scilex Holding Company (SCLX) vs. Its Peers: A Comparison

Additionally, the 36-month beta value for SCLX is 1.17. There are mixed opinions on the stock, with 2 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”

The public float for SCLX is 116.30M and currently, short sellers hold a 9.52% ratio of that float. The average trading volume of SCLX on October 16, 2024 was 873.63K shares.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

SCLX) stock’s latest price update

Scilex Holding Company (NASDAQ: SCLX)’s stock price has soared by 21.24 in relation to previous closing price of 0.81. Nevertheless, the company has seen a gain of 19.76% in its stock price over the last five trading days. globenewswire.com reported 2024-10-16 that PALO ALTO, Calif., Oct. 16, 2024 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, today announced that it anticipates the filing of the Registration Statement with the SEC before the end of October 2024 relating to the previously announced proposed Business Combination with Denali Capital Acquisition Corp. (Nasdaq: DECA) for a pre-transaction equity value of $2.5 billion which transaction is expected to occur by the end of fourth quarter of 2024 or the first quarter of 2025.

SCLX’s Market Performance

Scilex Holding Company (SCLX) has experienced a 19.76% rise in stock performance for the past week, with a -5.80% drop in the past month, and a -48.98% drop in the past quarter. The volatility ratio for the week is 6.57%, and the volatility levels for the past 30 days are at 10.49% for SCLX. The simple moving average for the past 20 days is 11.79% for SCLX’s stock, with a -28.85% simple moving average for the past 200 days.

Analysts’ Opinion of SCLX

Rodman & Renshaw, on the other hand, stated in their research note that they expect to see SCLX reach a price target of $13. The rating they have provided for SCLX stocks is “Buy” according to the report published on June 13th, 2024.

B. Riley Securities gave a rating of “Buy” to SCLX, setting the target price at $4 in the report published on October 16th of the previous year.

SCLX Trading at -6.71% from the 50-Day Moving Average

After a stumble in the market that brought SCLX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -62.75% of loss for the given period.

Volatility was left at 10.49%, however, over the last 30 days, the volatility rate increased by 6.57%, as shares sank -7.61% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -31.89% lower at present.

During the last 5 trading sessions, SCLX rose by +14.07%, which changed the moving average for the period of 200-days by -54.26% in comparison to the 20-day moving average, which settled at $0.8740. In addition, Scilex Holding Company saw -51.98% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at SCLX starting from Ji Henry, who purchase 50,000 shares at the price of $0.88 back on May 17 ’24. After this action, Ji Henry now owns 50,070 shares of Scilex Holding Company, valued at $43,985 using the latest closing price.

Chun Jay, the Director of Scilex Holding Company, purchase 57,500 shares at $0.90 during a trade that took place back on May 17 ’24, which means that Chun Jay is holding 102,500 shares at $51,641 based on the most recent closing price.

Stock Fundamentals for SCLX

Current profitability levels for the company are sitting at:

  • -1.95 for the present operating margin
  • 0.62 for the gross margin

The net margin for Scilex Holding Company stands at -2.34. The total capital return value is set at 0.66.

Based on Scilex Holding Company (SCLX), the company’s capital structure generated -0.96 points at debt to capital in total, while cash flow to debt ratio is standing at 0.12. The debt to equity ratio resting at -0.49. The interest coverage ratio of the stock is -45.77.

Currently, EBITDA for the company is -101.28 million with net debt to EBITDA at -1.05. When we switch over and look at the enterprise to sales, we see a ratio of 5.82. The receivables turnover for the company is 1.34for trailing twelve months and the total asset turnover is 0.49. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.20.

Conclusion

In conclusion, Scilex Holding Company (SCLX) has seen bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Most Popular

Related Posts